THERMOSTABLE RESPIRATORY SYNCTIAL VIRUS (RSV) VACCINE COMPOSITIONS
    3.
    发明申请
    THERMOSTABLE RESPIRATORY SYNCTIAL VIRUS (RSV) VACCINE COMPOSITIONS 审中-公开
    可呼吸呼吸道感染病毒(RSV)疫苗组合物

    公开(公告)号:US20160250319A1

    公开(公告)日:2016-09-01

    申请号:US15029064

    申请日:2014-10-13

    IPC分类号: A61K39/155 A61K47/26 C12N7/00

    摘要: Methods for improving the drying yield and stability of RSV vaccines comprising a highly thermolabile enveloped live virus and/or one or more RSV protein subunits, are described. Methods for rapid drying of RSV formulations containing between 17.5% and 60% w/w of a non-polymeric sugar and using either conduction or radiation dominant drying mechanisms, are disclosed. The disclosed methods provide for; 1) a dried RSV formulation with improved stability profile; 2) faster drying; and 3) integration of dried RSV into a primary device (such as dual chamber cartridges, foil-pouch devices etc.), pre- as well as post-drying.

    摘要翻译: 描述了改善包含高度不耐热的包膜活病毒和/或一个或多个RSV蛋白亚基的RSV疫苗的干燥产率和稳定性的方法。 公开了用于快速干燥含有17.5%至60%w / w的非聚糖的RSV制剂的方法,并且使用传导或辐射优势的干燥机理。 所公开的方法规定; 1)具有改善的稳定性特征的干燥的RSV制剂; 2)干燥速度更快; 以及3)将干燥的RSV整合到主要装置(例如双室筒,箔袋装置等)中,以及干燥后。

    LYOPHILIZED SPHERICAL PELLETS OF ANTI-IL-23 ANTIBODIES
    5.
    发明申请
    LYOPHILIZED SPHERICAL PELLETS OF ANTI-IL-23 ANTIBODIES 审中-公开
    抗IL-23抗体的LYOPHILIZED球形细胞

    公开(公告)号:US20150307606A1

    公开(公告)日:2015-10-29

    申请号:US14650605

    申请日:2013-12-09

    IPC分类号: C07K16/24 F26B5/06 A61K9/19

    摘要: Methods for preparing lyophilized pellets of antibodies that specifically bind to human IL-23 are described. The pellets have a substantially spherical shape and are prepared by freezing droplets of a liquid composition of a desired biological material on a flat, solid surface, in particular, a surface that does not have any cavities, followed by lyophilizing the frozen droplets. These methods are useful for preparing lyophilized pellets having a high concentration of anti-IL-23 antibody, and which have a faster reconstitution time than lyophilized powder cakes prepared in vials. Also provided are improved formulations for use in preparing lyophilized forms of antibodies that specifically bind to human IL-23.

    摘要翻译: 描述了制备特异性结合人IL-23的抗体冻干颗粒的方法。 颗粒具有基本上球形的形状,并且通过在平坦的固体表面,特别是没有任何空腔的表面上冷冻所需生物材料的液体组合物的液滴,然后冻结冷冻液滴来制备。 这些方法可用于制备具有高浓度抗IL-23抗体的冻干颗粒,并且比在小瓶中制备的冻干粉饼具有更快的重构时间。 还提供了用于制备特异性结合人IL-23的抗体的冻干形式的改进制剂。

    PROCESS FOR PREPARING FORMULATIONS FOR GASTROINTESTINAL-TARGETED THERAPIES

    公开(公告)号:US20180311172A1

    公开(公告)日:2018-11-01

    申请号:US15768044

    申请日:2016-10-11

    IPC分类号: A61K9/50 A61K9/00

    摘要: The present invention provides a process for preparing enterically-coated lyospheres comprising a therapeutic agent comprising: a.) providing lyospheres comprising the therapeutic agent; b.) coating said lyospheres with an enteric polymer coating composition; and c.) isolating said enterically-coated lyospheres. In other embodiments, the invention provides dosage forms comprising a lyosphere comprising an effective amount of a therapeutic agent and an enteric polymer coating. In some embodiments, the therapeutic agent in the process or dosage form is a polypeptide, a protein, a peptide, a lipopeptide, a glycoprotein, a fusion protein, a protein conjugate, a cytokine, an enzyme, an antibody, an oligonucleotide, a vaccine vector, small molecule, a live virus, an inactivated virus, a virus-like particle, a viral protein subunit, an adjuvant, microbiome, a prebiotic, a probiotic, or an ectobiotic. In some embodiments of the present invention, after oral administration the dosage forms containing the enterically-coated lyospheres provide a method of delivering a therapeutic agent to the ileum, ileo-caecal junction, colon or a combination thereof in a subject.